Overview
Congenital pulmonary valvar stenosis (also known as congenital pulmonary valve stenosis or congenital pulmonic stenosis) is a heart defect present at birth in which the pulmonary valve — the valve that controls blood flow from the right ventricle of the heart to the pulmonary artery and lungs — is abnormally narrowed. This narrowing (stenosis) obstructs blood flow from the heart to the lungs, forcing the right ventricle to work harder to pump blood through the restricted valve. The condition accounts for approximately 8–10% of all congenital heart defects. The pulmonary valve leaflets are often thickened, partially fused (commissural fusion), or dome-shaped, reducing the effective valve opening. Symptoms vary depending on the severity of the stenosis. Mild cases may be asymptomatic and detected only by the presence of a heart murmur during routine examination. Moderate to severe cases can cause exertional dyspnea (shortness of breath with activity), fatigue, chest pain, cyanosis (bluish discoloration of the skin due to reduced oxygen), and in neonates with critical stenosis, heart failure. Right ventricular hypertrophy develops as the heart compensates for the increased workload. In severe or critical cases, particularly in neonates, the condition can be life-threatening without prompt intervention. The primary treatment for moderate to severe congenital pulmonary valvar stenosis is balloon valvuloplasty (also called balloon valvotomy), a catheter-based procedure that dilates the narrowed valve. This procedure has excellent long-term outcomes and is considered the first-line intervention. Surgical valvotomy or valve replacement may be necessary in cases where the valve anatomy is not amenable to balloon dilation, such as when there is significant valve dysplasia. Mild stenosis typically requires no intervention but is monitored with periodic echocardiography. With appropriate treatment, the long-term prognosis is generally very good, though some patients may require re-intervention later in life due to residual stenosis or pulmonary regurgitation.
Also known as:
Clinical phenotype terms— hover any for plain English:
Multifactorial
Caused by a mix of several genes and environmental factors
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Congenital pulmonary valvar stenosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenital pulmonary valvar stenosis at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Congenital pulmonary valvar stenosis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenital pulmonary valvar stenosis.
Community
No community posts yet. Be the first to share your experience with Congenital pulmonary valvar stenosis.
Start the conversation →Latest news about Congenital pulmonary valvar stenosis
No recent news articles for Congenital pulmonary valvar stenosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenital pulmonary valvar stenosis
What is Congenital pulmonary valvar stenosis?
Congenital pulmonary valvar stenosis (also known as congenital pulmonary valve stenosis or congenital pulmonic stenosis) is a heart defect present at birth in which the pulmonary valve — the valve that controls blood flow from the right ventricle of the heart to the pulmonary artery and lungs — is abnormally narrowed. This narrowing (stenosis) obstructs blood flow from the heart to the lungs, forcing the right ventricle to work harder to pump blood through the restricted valve. The condition accounts for approximately 8–10% of all congenital heart defects. The pulmonary valve leaflets are ofte
How is Congenital pulmonary valvar stenosis inherited?
Congenital pulmonary valvar stenosis follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Congenital pulmonary valvar stenosis typically begin?
Typical onset of Congenital pulmonary valvar stenosis is neonatal. Age of onset can vary across affected individuals.